Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia

NCT05117346 is registered in ClinicalTrials.gov with Cardix Therapeutics LLC as lead sponsor.

NCT NCT05117346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05117346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
Lead sponsor
Cardix Therapeutics LLC
Phase
Phase 1/2
Overall status
Completed
Start date
December 1, 2022
Completion date
June 30, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia